UKTI Logo Sitemap | Help
Text size: a  a  a Home About Us How We Help Contact Us Events Downloads OurWorld  
 
 
My UK
Create email alerts
 
Why the UK?
Key advantages Business factors Investment regions Forming a company Living & leisure
 
Your business sector
Aerospace Automotive Creative industries Environment & renewable energy Financial & Business Services Food & drink ICT Life sciences Nanotechnology More sectors
 
UK advisory network
Welcome to the network Get professional advice Give professional advice Network news & events
OurWorld…passionate about business08-Jan-09
Welcome to UK Trade & Investment today

Fusion brings research to the market

University research is being helped to the marketplace by a Sheffield firm.

A Yorkshire-based company is working to provide the support researchers need to turn innovative ideas into commercially-viable products.

Fusion IP, which is based at the University of Sheffield's Bio-incubator, has signed a ten-year deal for the rights to the institution's research pipeline, according to the Financial Times.

'

Universities are very good at creating world-leading research but not so good at knowing what would make a company

David Baynes

CEO

Fusion IP

'

David Baynes, Chief Executive of company, revealed there are several stages the firm takes to help a start-up bring innovations to the market, such as using a professional manager who will help establish a business plan and determine funding requirements.

When the product is believed to be at a marketable stage, Fusion IP seeks new investors for the project, with larger enterprises eventually being sold to venture capitalists or listed on the London junior market.

Bioscience in the UK

Read our brochure about Bioscience in the UK

Explaining the role his firm plays, Mr Baynes told the newspaper: "Universities are very good at creating world-leading research but not so good at knowing what would make a company.

Among the start-ups Fusion has worked with are cell-transplantation technology company Abcellute, alternative energy firm Biohydrogen and Medella Therapeutics, which is creating new antibody drugs for cancerous tumours.



How can we help you?

Discover how our global network of business champions can help you achieve your goals.

We have personalised services for foreign investors, consultants, media/press, and students.